Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice.
about
The role of triterpenes in the management of diabetes mellitus and its complicationsBiochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenesActivation of AMPK by bitter melon triterpenoids involves CaMKKβHepatic FoxO1 acetylation is involved in oleanolic acid-induced memory of glycemic control: novel findings from Study 2.BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathyIdentification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream targetTargeting nrf2-mediated gene transcription by triterpenoids and their derivatives.Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.A 70% Ethanol Extract of Mistletoe Rich in Betulin, Betulinic Acid, and Oleanolic Acid Potentiated β-Cell Function and Mass and Enhanced Hepatic Insulin Sensitivity.Liver glycogen in type 2 diabetic mice is randomly branched as enlarged aggregates with blunted glucose release.Effects of oleanolic acid on the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic male Sprague-Dawley rats.Dammarenediol-II Prevents VEGF-Mediated Microvascular Permeability in Diabetic Mice.Erzhi Formula Extracts Reverse Renal Injury in Diabetic Nephropathy Rats by Protecting the Renal Podocytes
P2860
Q26799404-DED7EC63-334D-4597-91B4-B8A9259EB49AQ27023359-0F3A3FED-7095-4F33-8BBF-796C499B37B5Q28486994-2A31873D-E273-4809-9469-007DC0CCA991Q34183986-FF48084F-14D2-4DD3-8A25-49AC63087CAAQ34296727-9E462867-F6C4-4B68-9B92-5B6C95459826Q36016417-FCA8BD1C-0A8F-44A4-929A-A2709434965CQ37145435-2036B47C-0179-4AD4-8188-FB9D32C3425EQ38172884-DB107395-025F-470E-947B-D9E3A0F1CBB6Q38417095-98C2D1FD-5501-4B0C-8D5E-9F1067C4D9E7Q40370411-DD746D29-C985-42CD-B55F-C20FD1A68FEEQ46574534-0CD53171-A695-47A3-9859-9FD25FD8B472Q46665056-D6A4E40A-B02A-4436-A377-298E70CB37EFQ58711498-CF838F8C-E3D2-458C-8226-82BE8688BC3C
P2860
Oleanolic acid reduces hyperglycemia beyond treatment period with Akt/FoxO1-induced suppression of hepatic gluconeogenesis in type-2 diabetic mice.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@ast
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@en
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@nl
type
label
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@ast
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@en
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@nl
prefLabel
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@ast
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@en
Oleanolic acid reduces hypergl ...... nesis in type-2 diabetic mice.
@nl
P2093
P2860
P1433
P1476
Oleanolic acid reduces hypergl ...... enesis in type-2 diabetic mice
@en
P2093
Bronwyn D Hegarty
Edward W Kraegen
Ji-Ming Ye
Juan Carlos Molero
Tristan J Iseli
Yi-Ping Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0042115
P407
P577
2012-07-30T00:00:00Z